semaglutide mash approval CDSCO Clears Wegovy for — India's First GLP-1 for Liver Disease, India's drug regulator CDSCO approved Novo Nordisk's Wegovy (semaglutide 2.4mg) on 17 July 2026 for MASH, based on Health Canada has approved Wegovy®

Like its once-weekly counterpart, the pill is also approved to reduce cardiovascular risk, reinforcing the idea that GLP-1 medications are now viewed as long-term metabolic therapies rather than short-term weight-loss tools

2007;116:I1I7

doi:10.1186/1472-6963-10-159 Sarwer DB, Gasoyan H, Bauerle Bass S, Spitzer JC, Soans R, Rubin DJ

Reuben A, Koch DG, Lee WM., Acute Liver Failure Study Group

You may store your used pen at room temperature up to 86F (30C) after your injection

we accept all major PPO insurance plans Monthly check-ins Personalized support and guidance Transparent pricing NEW patient appointment: BOOK here EXISTING PATIENT follow up: BOOK HERE STEP 2: First Appointment 30 minute appointment to discuss your medical history and goals